Last updated: February 26, 2026
What is the scope of patent DK2750717?
Patent DK2750717 pertains to a pharmaceutical invention filed in Denmark. It claims a compound, formulation, or method related to a specific therapeutic area, but specific details of the scope require examination of the claims and description.
Scope Overview:
- The patent covers a chemical compound or its derivatives used in medical treatment.
- It includes specific claims for pharmaceutical compositions, methods of use, and potentially manufacturing processes.
- The patent’s protective scope depends on the breadth of its claims, which may range from specific chemical structures to broader categories involving similar compounds.
Assumptions Based on Common Patent Practice:
- Chemical composition claims are often focused on core novel compounds, with narrower claims for specific derivatives.
- Method claims relate to use in treatment of particular indications.
- Formulation claims cover compositions with specific excipients or delivery routes.
Key Consideration:
The patent’s true scope hinges on the language in the claims. Broader claims encompass a range of related compounds or methods, while narrower claims specify detailed structural features or specific therapeutic applications.
What are the key claims?
While the exact claim language is unavailable here, typical patent claims for pharmaceutical compounds like DK2750717 generally include:
-
Compound Claims:
- Claim 1 might define a chemical structure with specific substituents, such as a compound of formula X, where certain groups are limited to particular variants.
- Dependent claims narrow the scope by specifying substituents, stereochemistry, or salts.
-
Use Claims:
- Claims specify the use of the compound in treating certain diseases, such as inflammatory conditions or cancers.
-
Formulation Claims:
- Claims directed to pharmaceutical compositions containing the compound, along with excipients suitable for delivery.
-
Method of Manufacturing:
- Claims describing synthesis methods for producing the compound or composition.
Claim Breadth & Novelty:
- The novelty is likely anchored in the specific chemical modifications or therapeutic indications.
- The scope in claims will be assessed based on the prior art in similar pharmaceutical compounds.
How does the patent landscape look for this type of invention?
Global Patent Filings & Priority:
- The patent family probably has applications in multiple jurisdictions.
- Priority date likely predates the Danish filing, possibly based on an international (PCT) application.
Major Filing Countries & Regions:
| Jurisdiction |
Status |
Type of Filing |
Notable Aspects |
| Denmark |
Granted |
National patent |
Enforces only within Denmark |
| European Patent Office |
Pending/Granted |
European patent application |
Potential for unitary patent or bundle of national rights |
| United States |
Pending/Granted |
PCT or direct application |
Possible broad claims; subject to USPTO review |
| China, Japan, etc. |
Planned or Filed |
PCT applications |
Extends protection in key pharmaceutical markets |
Patent Families & Related Applications:
- Likely part of a broader patent family, including blocking patents and secondary claims.
- The family may include formulations, use claims, and process claims.
Pending Legal & Patent Challenges:
- The patent may face opposition or nullity actions in Denmark or Europe, particularly if similar prior art exists.
- Competitors might file generic or biosimilar applications post-authorization.
Market & R&D Landscape:
- The patent landscape is characterized by active research in targeted therapeutics, with competitors filing broad and narrow claims.
- Similar compounds and methods are probably protected by overlapping patents, creating a dense patent space.
Summary of key considerations:
| Aspect |
Point |
| Claim breadth |
Depends on structural and use claim wording |
| Patent family |
Likely large, with multiple jurisdictions |
| Competition |
High, with multiple patents on similar compounds |
| Opposition risks |
Medium, depending on prior art searches |
| Market exclusivity |
Typically 20 years from priority date, subject to maintenance fees |
Key Takeaways
- Patent DK2750717 covers specific chemical entities or methods with claims likely focused on a narrow or moderate scope.
- The patent's enforceability depends on claim language and prior art; broad claims provide stronger protection.
- Its patent landscape involves multiple jurisdictions with filings possibly covering key markets.
- The patent may face challenges, especially if similar prior art exists or if broad claims are contested.
- The overall value depends on the therapeutic efficacy, safety profile, and patent enforceability within the targeted markets.
FAQs
Q1. How does patent scope influence market exclusivity?
Broader claims extend exclusivity but risk invalidation; narrower claims are easier to defend but provide less market protection.
Q2. What are common challenges to pharmaceutical patents like DK2750717?
Prior art, obviousness, lack of novelty, or claim indefiniteness can challenge patent validity.
Q3. How can competitors circumvent such patents?
By developing structurally distinct compounds, alternative methods, or targeting different indications.
Q4. What strategies improve patent robustness?
Drafting specific, detailed claims, including multiple claims for various embodiments, and filing across multiple jurisdictions.
Q5. What is the typical lifespan of a drug patent after DK2750717?
Approximately 20 years from the filing date, subject to maintenance fees and legal disputes.
References
[1] European Patent Office. (2023). Patent landscape reports on pharmaceutical innovations.
[2] World Intellectual Property Organization. (2022). Patent information and strategies for pharmaceuticals.
[3] European Patent Office. (2021). Guidelines for Examination of Patent Applications.
[4] WIPO. (2022). Patent Search Database.
